Table with example of clinically relevant medication for extramural health professionals
back to page with additional documentation
An institution makes available all medication data recorded within the institution itself (all its own building blocks). These may not all be relevant to receiving health professionals. Querying information systems could therefore filter the data. However, some medicines administered during hospitalisation may still be important after discharge. For example, because they have a long-term effect that requires medication monitoring even after discharge. These should therefore not be filtered out in advance. Sectors and suppliers can jointly draw up a list for this purpose. The table below contains a list of examples of medicinal product groups that may be clinically relevant for extramural healthcare providers.
| ATC group code | Name |
|---|---|
| L01 | Cytostatics |
| L03AX03 | BCG vaccine urology |
| L04AA23; L04AA25; L04AA26; L04AA33; L04AA34; L04AB; L04AC | Immunosuppressants |
| B03AC; B03XA; B06AC | Iron, epo, agents against angioedema |
| G03GA; G03GB02 | Gonadotropins (HCG etc), clomiphene |
| H01CA; H01CC; L02AE04 | Gonadorelin, hypothalamic hormones, triptorelin |
| J06; J07 | Immunoglobulins, vaccines |
| M03AX01 | Botox |
| R03DX05 | Omalizumab |
| S01LA04; S01LA05; S01LA | Ophthalmic anti-neovascular agents |
Document history
| Version | Date | Description |
|---|---|---|
| 9 3.0.0-rc.2 | March 2026 | for all changes see: *Releasenotes |
